A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants
2022-06-27
عنوان الدراسة
A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants
داعم الدراسة
Novartis
دواء الدراسة
Everolimus + reduced tacrolimus VS.Tacrolimus
رقم بروتوكول الدراسة
CRAD001H2307
حالة الدراسة
Completed
موقع الدراسة
KFSH & RC-R
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。